Sort   by:  
 Page size 
TranscriptomicsLow input Hi-C datasets for a diffuse large B-cell lymphoma sample, healthy control human B-cells and mouse embryonic stem cells
In this experiment, we've examined chromatin conformation of OG2 (B6; CBA-Tg(Pou5f1-EGFP)2Mnn/J; stock number 004654) mouse stem cells cultured as described in (Shi et al., 2008), using different amounts of starting cells. We performed a modified in situ Hi-C protocol for 6 samples digested with Mbo...
ORGANISM(S): Mus musculus 
2018-11-30 | E-MTAB-5875 | biostudies-arrayexpress
ProteomicsProteome profiling of Campylobacter jejuni 81-176 at 37°C and 42°C by label-free mass spectrometry
Background: The main natural reservoir for Campylobacter jejuni is the intestinal tract of birds, especially in the context of human nutrition chickens and turkeys play the main role. There C. jejuni multiplies optimally at 42°C, the avian body temperature, while after infection of humans by peroral...
ORGANISM(S): Campylobacter jejuni 
2024-06-16 | PXD029494 | Pride
Mass spectrometry Temperature adaptation Data-independent acquisition Proteome Campylobacter jejuni 
UnknownCenani-Lenz syndactyly syndrome - a case report of a family with isolated syndactyly.
Not available
S-EPMC6057103 | biostudies-literature
ProteomicsSWATH-LC/MS/MS of the proteomic response in Campylobacter jejuni 81-176 to sublethal concentrations of seven different bile acids
To characterize the adaptation processes of C. jejuni to sublethal concentrations of bile acids, that are a crucial component of the intestinal antimicrobial defense, including cholic- , chenodeoxycholic-, taurocholic-, glycocholic-, deoxycholic-, lithocholic-, and ursodeoxycholic acid, we used prot...
ORGANISM(S): Campylobacter jejuni subsp. jejuni 81-176 
2018-10-01 | PXD009088 | Pride
Swath Bile acids Campylobacter 
UnknownShort-patch correction of C/C mismatches in human cells.
Not available
S-EPMC545458 | biostudies-literature
ProteomicsThe Golgi stacking protein GRASP55 is targeted by the natural compound prodigiosin
The bacterial secondary metabolite prodigiosin has been shown to exert anticancer, antimalarial, antibacterial and immunomodulatory properties. With regard to cancer, it has been reported to affect cancer cells but not non-malignant cells, rendering prodigiosin a promising lead compound for anticanc...
ORGANISM(S): Homo sapiens (Human) 
2023-10-24 | PXD043247 | Pride
Prodigiosin  golgi apparatus  natural compound  autophagy  target identification 
UnknownBCOR analysis in patients with OFCD and Lenz microphthalmia syndromes, mental retardation with ocular anomalies, and cardiac laterality defects.
Not available
S-EPMC2826145 | biostudies-literature
TranscriptomicsBacillus subtilis W168, WT vs. uppS-RBS (A to C)
Transcriptional profile of the uppS-RBS (A to C) mutant during log growth phase in LB medium. Bacillus subtilis W168, WT vs. uppS-RBS (A to C). The experiment was conducted two times using three independent total RNA preparations (biological triplicates). Each comparison was performed in dye-swap wi...
ORGANISM(S): Bacillus subtilis 
2013-04-01 | E-GEOD-45305 | biostudies-arrayexpress
UnknownProteome profiling of Campylobacter jejuni 81-176 at 37 °C and 42 °C by label-free mass spectrometry.
Not available
S-EPMC11140963 | biostudies-literature
UnknownLRP4 mutations alter Wnt/beta-catenin signaling and cause limb and kidney malformations in Cenani-Lenz syndrome.
Not available
S-EPMC2869043 | biostudies-literature
Sort   by:  
 Page size